Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × relatlimab × Clear all

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Carcinoma, Hepatocellular, Colorectal Neoplasms

NCT06561386 2026-05-20

RELATIVITY1093

Phase 3 Recruiting

1,000 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04623775 2025-10-20

A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

Phase 2 Active not recruiting

468 enrolled 24 charts

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04205552 2024-05-09

NEOpredict

Phase 2 Unknown

90 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

Clinical Trials

STELLAR-002

RELATIVITY1093

A Study of Relatlimab Plus Nivolumab in Combination With Chemotherapy vs. Nivolumab in Combination With Chemotherapy as First Line Treatment for Participants With Stage IV or Recurrent Non-small Cell Lung Cancer (NSCLC)

NEOpredict